New England Surgical Society (NESS)
Search NESS
  Home
  Annual Meeting
  Annual Resident and Fellow Research Day
  Members
      Member Directory
      Members Only
  Scholars Foundation
  Job Board
  Awards
  Journal of the American College of Surgeons
  Newsletters
  Committees
  Contact NESS

NESS 2006 Annual Meeting
Back to Scientific Program
Back to Annual Meeting


Contemporary Surgical Treatment of Neuroendocrine Tumors of the Pancreas
Vitaliy Y Poylin, Charles M Vollmer, Jr., Wande Pratt, Per-Olof Hasselgren, Mark P Callery
Beth Israel Deaconess Medical Center, Boston, MA

Objective: To analyze a recent surgical experience with pancreatic neuroendocrine tumors.
Design: Prospectively collected case series.
Setting: Academic referral center.
Patients: : Pancreatic resections for neuroendocrine tumors (2001-2006).
Main Outcome Measures: Demographics, symptoms, diagnostic modalities, tumor histology, type of surgical procedure, complications, and LOS.
Results: Twenty-six patients were evenly distributed between younger (<65) and older cohorts, with a 20-year difference in mean age at presentation (51.9 and 71.3 years) respectively. Overall, 28% were functional tumors with symptoms characteristic of the secreted hormone (6 insulinoma, 1 gastrinoma). Nonfunctioning tumors usually presented with abdominal pain, nausea and vomiting (n=16), or incidentally (n=3). 70% of patients required more then one of the following imaging modalities for diagnosis: CT, MRI, abdominal ultrasound, octreotide scan, or ERCP. Tumors were evenly distributed between head (n=11), body (n=7), and tail (n=8). When compared to the older cohort, younger patients' tumors were significantly bigger (5.25 vs. 1.4cm), predisposed towards the tail (42 vs. 25%), and were more often malignant (42% vs. 0%). Twenty-one patients had open surgical procedures including: pancreaticoduodenectomy (n=6), distal pancreatectomy (n=12), enucleation (n=2), or laparotomy with biopsy (n=1). Twenty percent of the cases were performed minimally invasively, with lower EBL and decreased LOS (8.3 vs. 4.6 days). Fifteen complications occurred in 12 patients (46%), with no operative (30 days) mortality.
Conclusions: Surgical management of pancreatic neuroendocrine tumors remains challenging owing to disease heterogeneity, difficulties in diagnosis, and the multitude of available surgical techniques, including laparoscopy.


Back to Scientific Program
Back to Annual Meeting

Copyright © 2018 New England Surgical Society. All Rights Reserved.
Read Privacy Policy.